NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on 21st October 2019, due to Assembly Elections in Maharashtra.

NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8%
Tue, 28 May

NATCO PHARMA has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:

NATCO PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-18*
3
Dec-18*
3
Mar-19*
QoQ ChangeYoY Change
Net SalesRs m7,6785,5674,557-18.1%-40.6%
Other incomeRs m20123331033.0%54.2%
TurnoverRs m7,8795,8004,867-16.1%-38.2%
ExpensesRs m3,8453,4833,074-11.7%-20.1%
Gross profitRs m3,8332,0841,483-28.8%-61.3%
DepreciationRs m1802072174.8%20.6%
InterestRs m306352-17.5%73.3%
Profit before taxRs m3,8242,0471,524-25.5%-60.1%
TaxRs m827454320-29.5%-61.3%
Profit after taxRs m2,9971,5931,204-24.4%-59.8%
Gross profit margin%49.937.432.5
Effective tax rate%21.622.221.0
Net profit margin%38.027.524.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 40.6% on a year-on-year (YoY) basis. The expenses were down by 20.1% YoY during the same period.
  • The company's operating profit declined by 61.3% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 32.5% in 4QFY19 as against 49.9% in 4QFY18.
  • Depreciation charges increased by 20.6% and finance costs increased by 73.3% YoY, respectively.
  • Other income increased by 54.2% YoY during the quarter.
  • Net profit for the quarter declined by 59.8% YoY. Net profit margins during the quarter declined from 38.0% in 4QFY18 to 24.7% in 4QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 18.1% on a quarter-on-quarter (QoQ) basis. The expenses were down by 11.7% QoQ during the same period.
  • The company's operating profit declined by 28.8% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 32.5% in 4QFY19 as against 37.4% in 3QFY18.
  • Net profit for the quarter declined by 24.4% QoQ, while net profit margins declined from 27.5% in 3QFY18 to 24.7% in 4QFY19.

To see how NATCO PHARMA has performed over the last eight quarters, please visit here.

NATCO PHARMA Share Price Performance

Over the last one year, NATCO PHARMA share price has moved up from Rs 796.7 to Rs 503.5, registering a Loss of Rs 293.2 or around 36.8%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,400.8 (up 0.3%). Over the last one year it has moved up from 13,319.5 to 13,400.8, a gain of 81 points (up 0.6%).

Overall, the S&P BSE SENSEX is up 12.7% over the year.

Current Valuations

At the current price of Rs 503.5, the price to earnings (P/E) ratio of NATCO PHARMA stands at 13.0 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 2.7 times.

Equitymaster requests your view! Post a comment on "NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8%". Click here!

  

Related Views on News

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 21.1% YoY). Sales on the other hand came in at Rs 5 bn (down 8.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 26.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (down 26.7% YoY). Sales on the other hand came in at Rs 6 bn (down 1.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Oct 18, 2019 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA 5-YR ANALYSIS

COMPARE NATCO PHARMA WITH

MARKET STATS